Skip to main content
OpenTrials

Clinical trial condition

Sarcoma, Clear Cell

Explore clinical trials studying Sarcoma, Clear Cell. Study availability and eligibility vary by location and protocol.

20 public trials 6 recruiting studies
Refine in advanced search Browse all conditions

Sarcoma, Clear Cell trial results

Completed

Radiation Therapy With or Without Combination Chemotherapy or Pazopanib Before Surgery in Treating Patients With Newly Diagnosed Non-rhabdomyosarcoma Soft Tissue Sarcomas That Can Be Removed by Surgery

NCT02180867

Conditions
Alveolar Soft Part Sarcoma, Angiomatoid Fibrous Histiocytoma, Atypical Fibroxanthoma, +65 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
  • The Kirklin Clinic at Acton Road Birmingham, Alabama, United States
  • Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
View all 381 locations
View Trial Details
Completed

Molecular-Guided Therapy for Childhood Cancer

NCT02162732

Conditions
Adenocarcinoma, Brain Diseases, Brain Neoplasms, +65 more
Locations
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Rady Children's Hospital San Diego, California, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Arnold Palmer Hospital for Children Orlando, Florida, United States
View all 19 locations
View Trial Details
Completed

Trial of Sunitinib and/or Nivolumab Plus Chemotherapy in Advanced Soft Tissue and Bone Sarcomas

NCT03277924

Conditions
Bone Diseases, Bone Neoplasms, Bone Sarcoma, +27 more
Locations
  • Istituto Ortopedico Rizzoli Bologna, Italy
  • Candiolo Cancer Institute - FPO, IRCCS Candiolo, Italy
  • Istituto Nazionale dei Tumori Milan, Italy
  • Hospital Universitario Fundación Jiménez Díaz Madrid, Spain
View all 13 locations
View Trial Details
Completed

CREATE: Cross-tumoral Phase 2 With Crizotinib

NCT01524926

Conditions
Granuloma, Granuloma, Plasma Cell, Hemic and Lymphatic Diseases, +27 more
Locations
  • Hôpitaux Universitaires Bordet-Erasme - Institut Jules Bordet Brussels, Belgium
  • U.Z. Gasthuisberg Leuven, Belgium
  • Institut Bergonie Bordeaux, France
  • Centre Georges-Francois-Leclerc Dijon, France
View all 25 locations
View Trial Details
Completed

To Evaluate Maximally Tolerated Dose (MTD), Safety and Efficacy of CPI-613® (Devimistat) Plus Hydroxychloroquine in Patients With Relapsed or Refractory Clear Cell Sarcoma of Soft Tissue

NCT04593758

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Connective Tissue, +3 more
Locations
  • City of Hope Duarte, California, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • University of Michigan Ann Arbor, Michigan, United States
  • Atrium Health Wake Forest Baptist Winston-Salem, North Carolina, United States
View Trial Details
Completed

Phase 2 Study in Patients With MiT Tumors

NCT00557609

Conditions
Adenocarcinoma, Alveolar Soft Part Sarcoma (ASPS), Carcinoma, +22 more
Locations
  • San Francisco, California, United States
  • Santa Monica, California, United States
  • Miami, Florida, United States
  • Boston, Massachusetts, United States
View Trial Details

Related conditions